Your browser doesn't support javascript.
loading
Rapid dynamic changes of FL.2 variant: A case report of COVID-19 breakthrough infection.
Choga, Wonderful T; Kurusa Gasenna, Gobuiwang Khilly; San, James Emmanuel; Ookame, Tidimalo; Gobe, Irene; Chand, Mohammed; Phafane, Badisa; Seru, Kedumetse; Matshosi, Patience; Zuze, Boitumelo; Ndlovu, Nokuthula; Matsuru, Teko; Maruapula, Dorcas; Bareng, Ontlametse T; Macheke, Kutlo; Kuate-Lere, Lesego; Tlale, Labapotswe; Lesetedi, Onalethata; Tau, Modiri; Mbulawa, Mpaphi B; Smith-Lawrence, Pamela; Matshaba, Mogomotsi; Shapiro, Roger; Makhema, Joseph; Martin, Darren P; de Oliveira, Tulio; Lessells, Richard J; Lockman, Shahin; Gaseitsiwe, Simani; Moyo, Sikhulile.
Affiliation
  • Choga WT; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; School of Allied Health Sciences, Faculty of Health Sciences, Gaborone, Botswana; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Afric
  • Kurusa Gasenna GK; Lenmed-Bokamoso Private Hospital, Gaborone, Botswana.
  • San JE; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory. Medicine and Medical Sciences, University of KwaZulu-Na
  • Ookame T; Ministry of Health and Wellness, Gaborone, Botswana.
  • Gobe I; School of Allied Health Sciences, Faculty of Health Sciences, Gaborone, Botswana.
  • Chand M; Diagnofirm Medical Laboratories, Plot 12583, Nyerere Drive MiddleStar, Gaborone, Botswana.
  • Phafane B; Diagnofirm Medical Laboratories, Plot 12583, Nyerere Drive MiddleStar, Gaborone, Botswana.
  • Seru K; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Matshosi P; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Zuze B; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Ndlovu N; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Matsuru T; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Maruapula D; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Bareng OT; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; School of Allied Health Sciences, Faculty of Health Sciences, Gaborone, Botswana.
  • Macheke K; National Health laboratory, Gaborone, Botswana.
  • Kuate-Lere L; National Health laboratory, Gaborone, Botswana.
  • Tlale L; National Health laboratory, Gaborone, Botswana.
  • Lesetedi O; National Health laboratory, Gaborone, Botswana.
  • Tau M; National Health laboratory, Gaborone, Botswana.
  • Mbulawa MB; National Health laboratory, Gaborone, Botswana.
  • Smith-Lawrence P; National Health laboratory, Gaborone, Botswana.
  • Matshaba M; Botswana-Baylor Children's Clinical Centre of Excellence, Gaborone, Botswana; Department of Pediatrics, Baylor College of Medicine, Houston, USA.
  • Shapiro R; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, USA.
  • Makhema J; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Martin DP; Institute of Infectious Diseases and Molecular Medicine, Division of Computational Biology, Department of Integrative Biomedical Sciences, University of Cape Town, South Africa.
  • de Oliveira T; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory. Medicine and Medical Sciences, University of KwaZulu-Na
  • Lessells RJ; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory. Medicine and Medical Sciences, University of KwaZulu-Na
  • Lockman S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, USA.
  • Gaseitsiwe S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, USA.
  • Moyo S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, USA; School of Health Systems and Public Health, University of Pretoria, South Africa; Division of Medical Virology, Faculty of Medici
Int J Infect Dis ; 138: 91-96, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37952911
ABSTRACT
We investigated intra-host genetic evolution using two SARS-CoV-2 isolates from a fully vaccinated (primary schedule x2 doses of AstraZeneca plus a booster of Pfizer), >70-year-old woman with a history of lymphoma and hypertension who presented a SARS-CoV-2 infection for 3 weeks prior to death due to COVID-19. Two full genome sequences were determined from samples taken 13 days apart with both belonging to Pango lineage FL.2 the first detection of this Omicron sub-variant in Botswana. FL.2 is a sub-lineage of XBB.1.9.1. The repertoire of mutations and minority variants in the Spike protein differed between the two time points. Notably, we also observed deletions within the ORF1a and Membrane proteins; both regions are associated with high T-cell epitope density. The internal milieu of immune-suppressed individuals may accelerate SARS-CoV-2 evolution; hence, close monitoring is warranted.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Aged / Female / Humans Country/Region as subject: Africa Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Aged / Female / Humans Country/Region as subject: Africa Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Document type: Article